Goldline Pharmaceutical Ltd.
30.10+0.1 (+0.40%)
23 Oct, 12:00 AM
Stock Scores
Quality Score
Score not available
Value Score
Score not available
Price Momentum Score
Score not available
QVM Score
Score not available
Key Metrics
Stock Analysis
Fundamental analysis overview of Goldline Pharmaceutical Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Stock is cheap and PE TTM is at a discount to industry median
PE TTM of 7.02 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -76.96%
What is P/E Ratio?
Median: 30.47
Value 7.02
-0.82614.73
Negative
Low dividend yield
The company has a low dividend yield of 0.0%
What is Dividend yield?
Neutral
Not enough talking points with neutral stance
Financial Snapshot
See detailed analysisMulti-year trends for Goldline Pharmaceutical Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
Net Revenue FY
Profit After Tax FY
ROE FY
EBITDA FY
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in Goldline Pharmaceutical Ltd. shares as reported to NSE and BSE.
| Name | Month | Transaction | Holding % pre transaction | Average price | Qty. | Transaction value |
|---|---|---|---|---|---|---|
Amol Laxmikant Mujumdar Promoter and Director | September-2026 | Market Purchase (Acquisition) 1st Sep 2026 | 29.27 % | ₹ 0.00 | 18.00 k | ₹ 0.00 |
Prashant Shrikrishna Karkare Director | July-2026 | Market Purchase (Acquisition) 29th Jul 2026 | 0.00 % | ₹ 0.00 | 27.00 k | ₹ 0.00 |
Swapan Khandelwal Promoter & Director | June-2026 | Market Purchase (Acquisition) 23rd Jun 2026 | 28.65 % | ₹ 43.27 | 60.00 k | ₹ 25.96 lac |
No corporate action data available.
Company Profile
Overview of Goldline Pharmaceutical Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
Goldline Pharmaceutical Limited is an India-based company, which is engaged in the business of marketing pharmaceutical products under the brand name Goldline. The Companys product portfolio is organized into five segments: Goldline Pharma, Goldline Cardinal, Goldline Aayushman, Goldline InLife, and...
Key personnel
Ms. Dipti Sharad Bhusari
Chief Financial Officer
Ms. Ruchi Sanket Modi
Company Secretary, Compliance Officer
Mr. Amol Laxmikant MujumdarD
Executive Chairman of the Board, Managing Director
Mr. Avinash Pandurang AmbulkarD
Executive Director
Mr. Prashant Shrikrishna KarkareD
Executive Director
Mr. Swapan Premprakash KhandelwalD
Whole Time Director
Dr. Prashant Vithalrao RahateD
Non-Executive Director
Ms. Renuka Saurabh BoroleD
Independent Director
View all
Incorporated on
02 Aug 2004
Last Annual
31 Mar 2026
Last Interim
31 Mar 2026
No. of Employees
126
IPO date
-
Free Float
19,26,015
Website
Phone no.
+917122786666
Address
Plot No.103, F-1, Leela Apartment, Shilpa Society, Near Shanidham, Saptagiri Nagar, NAGPUR, 440015, India
Frequently Asked Questions
What is the current share price of Goldline Pharmaceutical Ltd.?
The current share price of Goldline Pharmaceutical Ltd. is ₹ 30.10 as of 23 Oct 2026.
What is the market capitalisation of Goldline Pharmaceutical Ltd.?
The market capitalisation of Goldline Pharmaceutical Ltd. stands at ₹ 28.90 Cr.
What is the PE ratio of Goldline Pharmaceutical Ltd.?
The Price-to-Earnings (PE) ratio of Goldline Pharmaceutical Ltd. is 7.02 as of the latest trailing twelve months data.
What is the ROE and ROCE of Goldline Pharmaceutical Ltd.?
Goldline Pharmaceutical Ltd. has a Return on Equity (ROE) of 33.47% and a Return on Capital Employed (ROCE) of 29.91% as per the latest financial reports.
What is the 52-week high and low of Goldline Pharmaceutical Ltd.?
The 52-week high of Goldline Pharmaceutical Ltd. is - and the 52-week low is -.
What is the dividend yield of Goldline Pharmaceutical Ltd.?
The dividend yield of Goldline Pharmaceutical Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in Goldline Pharmaceutical Ltd.?
Foreign Institutional Investors (FII) hold 0.31%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 37.60% of Goldline Pharmaceutical Ltd. shares.
What sector does Goldline Pharmaceutical Ltd. belong to?
Goldline Pharmaceutical Ltd. operates in the Healthcare sector.
What is the beta of Goldline Pharmaceutical Ltd.?
The beta of Goldline Pharmaceutical Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of Goldline Pharmaceutical Ltd.?
The 14-day Relative Strength Index (RSI) of Goldline Pharmaceutical Ltd. is 34.61, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.